Xiamen Amoytop Biotech Co., Ltd. Class ASSE: 688278

"Xiamen Amoytop Biotech Co., Ltd."Voluntary Disclosure Announcement on ACT201 Injection Obtaining Notice of Approval for Drug Clinical Trial

· Issued by Xiamen Amoytop Biotech Co., Ltd. Class A via Shanghai Stock Exchange
Voluntary Disclosure Announcement on ACT201 Injection Obtaining Notice of Approval for Drug Clinical Trial

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis